stockportfolio.pro
Stocks / MDGL vs MOH
MDGL vs MOH
Madrigal Pharmaceuticals, Inc. and Molina Healthcare, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
MDGL is the larger company ($11.0B vs $10.3B). On the fundamentals, MOH earns a higher net margin (1.0% vs -30.1%); MOH has the stronger return on equity (11.6% vs -47.8%). Full numbers below — the stronger figure on each row is in green.
| Madrigal Pharmaceuticals, Inc. (MDGL) | Molina Healthcare, Inc. (MOH) | |
|---|---|---|
| Market cap | $11.0B | $10.3B |
| Revenue (latest FY) | $958.40M | $45.43B |
| Net income (latest FY) | $-288.28M | $472.00M |
| Revenue growth (5y CAGR) | — | 18.5% |
| Net margin | -30.1% | 1.0% |
| Return on equity | -47.8% | 11.6% |
| P/E ratio | — | 52.7 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 9 |
| Positive free cash flow | No | No |
Compare with another company:
See the full MDGL vs MOH breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open MDGL's full financials → Open MOH's full financials →More comparisons
Frequently asked questions
Which is bigger, MDGL or MOH?
Madrigal Pharmaceuticals, Inc. is larger by market capitalization — $11.0B versus $10.3B.
Which grows faster, MDGL or MOH?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
MDGL fundamentals → · MOH fundamentals → · All 1,500+ companies → · Free screener →